Kodiak Sciences Inc.

KOD ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Assets
Cash & Equivalents $209.9M $168.1M $285.5M $190.4M $731.5M $944.4M $211.8M $88.3M
Accounts Receivable — — — — — — — —
Inventory — — — — — — — —
Total Current Assets $214.8M $171.9M $289.3M $486.0M $734.8M $972.0M $339.2M $90.4M
Property, Plant & Equipment $85.3M $102.2M $120.5M $56.4M $41.3M $5.1M $996.0K $1.1M
Goodwill — — — — — — — —
Intangible Assets (Excl. Goodwill) — — — — — — — —
Total Assets $351.5M $335.6M $479.4M $666.6M $904.2M $1.07B $358.9M $92.2M
Liabilities
Accounts Payable $12.9M $3.9M $13.6M $9.1M $12.4M $8.6M $2.6M $1.1M
Total Current Liabilities $45.5M $25.6M $41.7M $52.5M $64.7M $31.4M $11.7M $4.8M
Long-Term Debt — — — — — — — —
Total Liabilities $194.2M $185.3M $213.6M $230.5M $240.9M $206.6M $13.5M $5.4M
Stockholders' Equity
Retained Earnings $-1.56B $-1.33B $-1.15B $-892.0M $-558.2M $-291.2M $-158.1M $-110.8M
Total Stockholders' Equity $157.4M $150.3M $265.8M $436.2M $663.3M $860.8M $345.4M $86.8M
← Newer Page 1 of 2 Older →